SH3PXD2A and central nervous system cancer: To further confirm these results, we evaluated the expression levels of SH3PXD2B, SH3PXD2A and EFHD2 mRNAs and encoded proteins in IDH-wt glioma cells (U87MG and T98G) overexpressing miR-1, miR-26a-1 and miR-487b, respectively.